Ofatumumab As Part Of The Conditioning Regimen For Patients With High Risk Chronic Lymphocytic Leukaemia Undergoing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation. A Pilot Trial From The Geth And Gellc (Nct01455051)
BONE MARROW TRANSPLANTATION（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要